Drug class
Dacarbazine
Dacarbazine is a specific antineoplastic active ingredient rather than a distinct therapeutic class; pharmacologically, it belongs to the alkylating drug class and the triazene structural family. Read more about Dacarbazine
3 drugs in this class 3 manufacturers
Drugs in Dacarbazine
DACARBAZINE
DACARBAZINE
Dacarbazine is a specific antineoplastic active ingredient rather than a distinct therapeutic class; pharmacologically, it belongs to the alkylating drug class and the triazene structural family.
It functions primarily as a cell-cycle non-specific prodrug that undergoes hepatic activation to alkylate DNA, inhibiting DNA replication, RNA transcription, and protein synthesis to induce cancer cell death.
Therapeutically, dacarbazine is indicated for the treatment of metastatic malignant melanoma and as a component of combination chemotherapy regimens for advanced Hodgkin lymphoma, while also being utilized in select soft tissue sarcomas.
-
fda.gov
Dacarbazine is a specific antineoplastic active ingredient rather than a distinct therapeutic class; pharmacologically, it belongs to the alkylating drug class and the triazene structural family
-
drozdogan.com
Dacarbazine is a specific antineoplastic active ingredient rather than a distinct therapeutic class; pharmacologically, it belongs to the alkylating drug class and the triazene structural family It functions primarily as a cell-cycle non-specific prodrug that undergoes hepatic activation to alkylate DNA, inhibiting DNA replication, RNA transcription, and protein synthesis to induce cancer cell death Therapeutically, dacarbazine is indicated for the treatment of metastatic malignant melanoma and ...
-
drugbank.com
It functions primarily as a cell-cycle non-specific prodrug that undergoes hepatic activation to alkylate DNA, inhibiting DNA replication, RNA transcription, and protein synthesis to induce cancer cell death
-
fpnotebook.com
It functions primarily as a cell-cycle non-specific prodrug that undergoes hepatic activation to alkylate DNA, inhibiting DNA replication, RNA transcription, and protein synthesis to induce cancer cell death
-
cancer.gov
Therapeutically, dacarbazine is indicated for the treatment of metastatic malignant melanoma and as a component of combination chemotherapy regimens for advanced Hodgkin lymphoma, while also being utilized in select soft tissue sarcomas
-
pfizer.com
Therapeutically, dacarbazine is indicated for the treatment of metastatic malignant melanoma and as a component of combination chemotherapy regimens for advanced Hodgkin lymphoma, while also being utilized in select soft tissue sarcomas
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.